Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
The company also reported significant progress toward its internally defined Sustainable Development Goals
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
The initiative is focused on a problem that continues to plague cancer outcomes in India
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The state-of-the-art facility is expected to be commissioned over the next three years
Subscribe To Our Newsletter & Stay Updated
